GlassScriptPhysician profile
Kent W Erb
NPI 1689757684
$3,024.55
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $898 · 2021: $1,227.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $416.17 | 2019-2021 | |
| Amarin Pharma, INC. | $363.63 | 2019-2021 | |
| Abbvie INC. | $328.95 | 2019-2021 | |
| Lilly USA, LLC | $216.09 | 2019-2021 | |
| Amgen INC. | $208.74 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $194.81 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.43 | 2019-2020 | |
| Allergan, INC. | $146.07 | 2020 | |
| Merck Sharp & Dohme LLC | $139.07 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.94 | 2019-2021 | |
| Pfizer INC. | $100.91 | 2019-2020 | |
| Novo Nordisk INC | $94.34 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $47.83 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $41.72 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $40.23 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $39.60 | 2021 | |
| Xeris Pharmaceuticals, INC. | $31.01 | 2021 | |
| Dexcom, INC. | $30.36 | 2021 | |
| Sanofi-Aventis U.S. LLC | $30.31 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.80 | 2021 | |
| Astellas Pharma US INC | $27.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.42 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.37 | 2020 | |
| Nestle Healthcare Nutrition INC. | $18.86 | 2021 | |
| Dynavax Technologies Corporation | $18.23 | 2019 | |
| Medtronic USA, INC. | $17.55 | 2019 | |
| Shire North American Group INC | $16.99 | 2019 | |
| Eisai INC. | $16.24 | 2020 | |
| Horizon Therapeutics Plc | $15.05 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.51 | 2020 | |
| Tactile Systems Technology INC | $14.35 | 2019 | |
| Philips North America LLC | $14.25 | 2021 | |
| Supernus Pharmaceuticals, INC. | $13.08 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $10.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Erb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.